A method for treating a cancer which overexpresses any of N-myc genes, C-myc genes and/or L-myc genes in a mammalian body, the method comprising:administering a composition to the mammalian body, wherein the composition comprises at least one from the group consisting of taurolidine； taurultam； taurinamide； methylene glycol； taurultam and taurinamide in a ratio of 1 taurultam:7 taurinamide； and taurultam, taurinamide and methylene glycol in a ratio of 1 taurultam:7 taurinamide:1 methylene glycol.
